<DOC>
	<DOCNO>NCT01136317</DOCNO>
	<brief_summary>This study aim determine , obese subject , antisecretory effect single dose placebo , rabeprazole 20 mg omeprazole 20 mg use 24h gastric pH monitoring , prospective , monocentre , randomized manner . Monitorings separate 6 and10 day . The main outcome criterion analysis percentage time gastric pH 3 24hours .</brief_summary>
	<brief_title>Comparison Antisecretory Effect Single Dose Rabeprazole 20 mg Omeprazole 20 mg Obese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Rabeprazole</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>Helicobacter negative obese subject ( BMI 30 40 ) , 18 55 year old , normal hepatic biology morphology ( echography ) Contraceptive method woman . Subjects previous abdominal surgery , diabetic immunosuppressive treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>